Peter Lebowitz, MD, PhD

Peter Lebowitz currently serves as the CEO of Third Arc Bio. Prior to Third Arc, he was the Global Head of Oncology R&D for Johnson & Johnson, where he built a world-class, end-to-end J&J oncology team that delivered 13 new oncology drugs by leveraging both internal R&D excellence and external partnerships. Peter also held senior leadership positions in discovery and early/late-stage clinical development at GlaxoSmithKlein. Throughout his tenure in the pharmaceutical industry, he achieved 15 major product approvals and successfully filed over 40 Investigational New Drug applications. Peter also served as Assistant Professor of Medicine, Division of Hematology/Oncology at the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, where he established a translational and clinical research program as a practicing oncologist. Peter graduated magna cum laude from Harvard University and received his M.D. and Ph.D. from the University of Pennsylvania School of Medicine. He completed his postgraduate clinical training in Internal Medicine at Duke University Medical Center and his Hematology/Oncology fellowship at the National Cancer Institute, National Institute of Health.